These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29191137)

  • 1. Racial-Ethnic Differences in Patterns of Discontinuous Medication Treatment Among Medicaid-Insured Youths With ADHD.
    Ji X; Druss BG; Lally C; Cummings JR
    Psychiatr Serv; 2018 Mar; 69(3):322-331. PubMed ID: 29191137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of long-acting medications on attention-deficit/hyperactivity disorder treatment disparities.
    Saloner B; Fullerton C; McGuire T
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):401-9. PubMed ID: 23952187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and Ethnic Differences in Minimally Adequate Depression Care Among Medicaid-Enrolled Youth.
    Cummings JR; Ji X; Lally C; Druss BG
    J Am Acad Child Adolesc Psychiatry; 2019 Jan; 58(1):128-138. PubMed ID: 30577928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receipt of Medication and Behavioral Therapy Among a National Sample of School-Age Children Diagnosed With Attention-Deficit/Hyperactivity Disorder.
    Walls M; Allen CG; Cabral H; Kazis LE; Bair-Merritt M
    Acad Pediatr; 2018 Apr; 18(3):256-265. PubMed ID: 29061327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial-Ethnic Differences in ADHD Diagnosis and Treatment During Adolescence and Early Adulthood.
    Adams SM; Riley T; Quinn PD; Meraz R; Karna V; Rickert M; D'Onofrio BM
    Psychiatr Serv; 2024 Jun; 75(6):521-527. PubMed ID: 38239182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial Disparities in Diagnosis of Attention-Deficit/Hyperactivity Disorder in a US National Birth Cohort.
    Shi Y; Hunter Guevara LR; Dykhoff HJ; Sangaralingham LR; Phelan S; Zaccariello MJ; Warner DO
    JAMA Netw Open; 2021 Mar; 4(3):e210321. PubMed ID: 33646315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethnic Disparities in School-Based Behavioral Health Service Use for Children With Psychiatric Disorders.
    Locke J; Kang-Yi CD; Pellecchia M; Marcus S; Hadley T; Mandell DS
    J Sch Health; 2017 Jan; 87(1):47-54. PubMed ID: 27917490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial and Ethnic Differences in ADHD Treatment Quality Among Medicaid-Enrolled Youth.
    Cummings JR; Ji X; Allen L; Lally C; Druss BG
    Pediatrics; 2017 Jun; 139(6):. PubMed ID: 28562259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A decline in depression treatment following FDA antidepressant warnings largely explains racial/ethnic disparities in prescription fills.
    Carson NJ; Progovac AM; Wang Y; Cook BL
    Depress Anxiety; 2017 Dec; 34(12):1147-1156. PubMed ID: 28962069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and ethnic disparities in ADHD diagnosis from kindergarten to eighth grade.
    Morgan PL; Staff J; Hillemeier MM; Farkas G; Maczuga S
    Pediatrics; 2013 Jul; 132(1):85-93. PubMed ID: 23796743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial/ethnic variation in asthma status and management practices among children in managed medicaid.
    Lieu TA; Lozano P; Finkelstein JA; Chi FW; Jensvold NG; Capra AM; Quesenberry CP; Selby JV; Farber HJ
    Pediatrics; 2002 May; 109(5):857-65. PubMed ID: 11986447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004-2006.
    Pastor PN; Reuben CA
    Vital Health Stat 10; 2008 Jul; (237):1-14. PubMed ID: 18998276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining psychotropic medication use among youth in the U.S. by race/ethnicity and psychological impairment.
    Cook BL; Carson NJ; Kafali EN; Valentine A; Rueda JD; Coe-Odess S; Busch S
    Gen Hosp Psychiatry; 2017; 45():32-39. PubMed ID: 28274336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and ethnic disparities in use of 17-alpha hydroxyprogesterone caproate for prevention of preterm birth.
    Yee LM; Liu LY; Sakowicz A; Bolden JR; Miller ES
    Am J Obstet Gynecol; 2016 Mar; 214(3):374.e1-6. PubMed ID: 26829989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of attention-deficit hyperactivity disorder: patterns of evolving care during the first treatment episode.
    Stein BD; Klein GR; Greenhouse JB; Kogan JN
    Psychiatr Serv; 2012 Feb; 63(2):122-9. PubMed ID: 22302328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of treatment engagement in an ADHD primary care-based intervention for urban families.
    Walton JR; Mautone JA; Nissley-Tsiopinis J; Blum NJ; Power TJ
    J Behav Health Serv Res; 2014 Oct; 41(4):539-47. PubMed ID: 24435226
    [No Abstract]   [Full Text] [Related]  

  • 17. Ethnic and regional differences in primary care visits for attention-deficit hyperactivity disorder.
    Stevens J; Harman JS; Kelleher KJ
    J Dev Behav Pediatr; 2004 Oct; 25(5):318-25. PubMed ID: 15502548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial/ethnic disparities in ADHD diagnosis by kindergarten entry.
    Morgan PL; Hillemeier MM; Farkas G; Maczuga S
    J Child Psychol Psychiatry; 2014 Aug; 55(8):905-13. PubMed ID: 24456307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial disparity in psychotropic medications prescribed for youths with Medicaid insurance in Maryland.
    Zito JM; Safer DJ; dosReis S; Riddle MA
    J Am Acad Child Adolesc Psychiatry; 1998 Feb; 37(2):179-84. PubMed ID: 9473914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.